NEW YORK (CBSNewYork) - Every year, nearly 800,000 people in the U.S. suffer a stroke - a leading cause of death and disability. CBS2's Dr. Max Gomez reports there's now a small, implantable device ...
Dual antiplatelet therapy (DAPT) can be used for 45 days after implantation of the Watchman FLX left atrial appendage closure device (Boston Scientific), according to labeling changes approved by the ...
On the basis of outcomes, there was no clear winner from a trial that directly compared two modern devices used in patients undergoing percutaneous left atrial appendage (LAA) closure. But the devices ...
A Watchman is a device that can help prevent blood clots from leaving the heart. However, the procedure to insert the device carries its risks, including cardiac tamponade and ischemic stroke. The ...
More special care is needed when using the Watchman access systems used to deliver transcatheter left atrial appendage (LAA) closure devices due to a risk for air embolisms, according to an FDA alert.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback